Cargando…

The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)

OBJECTIVE: Medication adherence in type 2 diabetes mellitus (T2DM) improves glycemic control and is associated with reduced adverse clinical events, and accurately assessing adherence assessment is important. We aimed to determine agreement between two commonly used adherence measures—the self-repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelly, Katherine, Grau-Sepulveda, Maria V, Goldstein, Benjamin A, Spratt, Susan E, Wolfley, Anne, Hatfield, Vicki, Murphy, Monica, Jones, Ellen, Granger, Bradi B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932248/ https://www.ncbi.nlm.nih.gov/pubmed/27403322 http://dx.doi.org/10.1136/bmjdrc-2015-000182

Ejemplares similares

New-Onset Type 1 Diabetes Mellitus (T1DM) in a Pediatric Patient with Beckwith-Wiedemann Syndrome
por: Ehsan, Lubaina, et al.
Publicado: (2023)

Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus
por: Sapkota, Lokendra Bahadur, et al.
Publicado: (2017)

Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation With Microvascular Complications
por: Hulkoti, Vidyashree, et al.
Publicado: (2022)

Detecting Frailty in Elderly Type 2 Diabetes Mellitus (T2DM) Patients in the Southeast of Brazil
por: Ramos-Dias, João Carlos, et al.
Publicado: (2021)

Clinical profile of diabetes mellitus in tuberculosis
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2015)

Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study
por: Idris, Iliza, et al.
Publicado: (2018)

Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation
por: Stedman, Mike, et al.
Publicado: (2020)

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
por: Davidson, Jaime A, et al.
Publicado: (2014)

National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM)
por: Al-Rubeaan, Khalid
Publicado: (2015)

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
por: Tuttle, Katherine R., et al.
Publicado: (2021)

FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
por: M, Aushili, et al.
Publicado: (2023)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

Excellent Outcome of Protocol-Based Treatment of Motivated Type 2 Diabetes Mellitus (T2DM) Patients: A Real World Follow-Up for 11 Years
por: Chatterjee, Sudip, et al.
Publicado: (2020)

Challenges in the Management of Type 1 Diabetes Mellitus (T1DM) in a Pediatric Patient Due to Social Determinants of Health: A Case Report
por: Gianvecchio, Crystal, et al.
Publicado: (2023)

Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus
por: Mannar, Velmurugan, et al.
Publicado: (2023)

Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle Modification
por: Li, Matthias, et al.
Publicado: (2023)

SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
por: Obukhov, Alexander G., et al.
Publicado: (2020)

Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults
por: Lv, Jun, et al.
Publicado: (2017)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Air Pollution and Type 2 Diabetes: Mechanistic Insights
por: Rajagopalan, Sanjay, et al.
Publicado: (2012)

The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial
por: Soare, Andreea, et al.
Publicado: (2015)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

Missing signposts on the roadmap to quality: a call to improve medication adherence indicators in data collection for population research
por: Granger, Bradi B., et al.
Publicado: (2013)

Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
por: Bonner-Weir, Susan, et al.
Publicado: (2008)

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
por: Frias, Juan Pablo, et al.
Publicado: (2021)

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Khayyat, Yara A, et al.
Publicado: (2022)

Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
por: Ling, Charlotte, et al.
Publicado: (2009)

Restricted Adipogenesis in Hypertrophic Obesity: The Role of WISP2, WNT, and BMP4
por: Gustafson, Birgit, et al.
Publicado: (2013)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
por: Beitelshees, Amber L., et al.
Publicado: (2019)

Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2019)

Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
por: Nishimura, Rimei, et al.
Publicado: (2019)

Culture-centered approaches: the relevance of assessing emotional health for Latinos with type 2 diabetes
por: Concha, Jeannie Belinda, et al.
Publicado: (2015)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
por: Moon, Hyun-Seuk, et al.
Publicado: (2011)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?
por: Liu, Jiwen (Jim), et al.
Publicado: (2012)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l79jrqg0scvu8mj5v88u5r6491